Utah Medical Products Inc (UTMD)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $68.84
- As of
Kresmion compiles this page from UTMD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
UTAH MEDICAL PRODUCTS INC (UTMD): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-22.
See the full UTMD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for UTMD on one page. Preview it with sample data, then open it live with a free account.
Preview the UTMD dossierActive events for UTMD
- mediumEarnings below estimates
Q1-2014: Missed consensus by 10.6% - EPS $0.72 vs $0.8058 estimate
FREE, NO ACCOUNT
Every event on UTMD, as it fires
New filings, 13F moves and cross asset events on UTMD land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in UTMD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 917488108 · 2026Q2 | $12.1M | 0.02% | , |
| D. E. Shaw & Co., Inc.CUSIP 917488108 · 2026Q2 | $603K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, UTMD
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
UTMD against its peers
UTMD's operating margin of 29.6% ranks in the 92nd percentile of 18 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | UTMD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 38.5M USD | 38.3M USD | 53 | 17 |
| Gross margin | 57.1% | 61.9% | 42 | 17 |
| Operating margin | 29.6% | -36.3% | 92 | 18 |
| Net margin | 29.3% | -34.6% | 92 | 18 |
| Return on equity | 9.5% | -17.8% | 81 | 17 |
| P / E | 19.8x | n/a | n/a | 3 |
Peers (19): PDEX, OSUR, SMTI, NNNN, ZJYL, KRMD, EMBC, STXS, AVR, NYXH, MBOT, POCI, NEPH, HBIO, KMTS, BLFS, MLSS, RVP, BNGO. Left out: DAVI (no annual filing), DXR (no annual filing), ZTEKF (no annual filing), AZTA (no annual filing), PLSE (no annual filing), SHTPY (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (UTMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow UTMD on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to UTMD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.